The downregulation of WNT1 observed in particular BC subtypes corroborates the work by Koval and Katanaev (2018), who reported low expression of this gene in primary tumors of nontriple-negative BC patients (ER+/PR + and HER+). Here, ESR1 is linked to breast cancer.